Mitochondrial calcium uptake in Alzheimer's disease
Mitochondrial calcium uptake in Alzheimer's disease
批准号:
10055513
负责人:
Pooja Jadiya
金额:
$10.41万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-15 至 2022-07-31
关键词:
3xTg-AD mouseAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-ProteinAmyloidosisAutophagocytosisBrainCalciumCause of DeathCell DeathCell Death Signaling ProcessCell LineCell RespirationCellular StressCessation of lifeClinicalCoupledDataDefectDevelopmentDiseaseDisease ProgressionEconomic BurdenEstrogen receptor positiveEventExhibitsGenesGeneticGenetic ModelsImpaired cognitionImpairmentLinkMediatingMedical Care CostsMemoryMemory LossMetabolicMetabolic dysfunctionMitochondriaMitochondrial MatrixModelingMolecularMolecular WeightMusMutant Strains MiceNerve DegenerationNeurofibrillary TanglesNeuronal DysfunctionNeuronsOxidative StressPathogenesisPathogenicityPathologicPathologyPathway interactionsReactive Oxygen SpeciesReportingResearchRoleSamplingSenile PlaquesSignal PathwaySignal TransductionSynapsesTestingTimeToxic effectTrainingTransgenic Miceabeta depositionage relatedcalcium uniportercareercognitive skillextracellulargain of functionhyperphosphorylated taumisfolded proteinmitochondrial dysfunctionmitochondrial permeability transition poremutantneuron lossneuropathologynew therapeutic targetnovel therapeutic interventionoverexpressionparalogous geneprotein aggregationproteostasisscaffoldstoichiometrytau Proteinsuptake
中文摘要
摘要:
阿尔茨海默病(AD)的特征是记忆丧失并伴有神经细胞死亡和
代谢功能障碍。许多研究已经报道了神经细胞内钙离子的失调。
(iCa+)信号转导是AD发病机制中的早期事件。据认为,神经元的长期抬高
钙离子促进线粒体钙的过度摄取,但到目前为止还没有研究检查
线粒体钙摄取在疾病进展中的作用。由于mCa~(2+)流量是细胞内重要的调节因子
呼吸和细胞死亡,这两个都与AD的发病有关,我们假设mCa~(2+)
超负荷是AD病理的关键因素,并可能导致代谢缺陷和神经元死亡。
为了确定线粒体钙交换在阿尔茨海默病中的作用,我们建立了3xTg-AD突变小鼠,小鼠具有神经元特异性
线粒体钙单一转运体(MCU)的缺失,这是线粒体摄取钙所必需的。此外,我们还有
产生了一个功能获得突变的小鼠,表达了最近发现的线粒体钙单转运体
β亚基(MCUb)。MCUb最近被报道为mCa~(2+)摄取的负调节因子,我们已经
观察到其在AD中的表达发生了实质性变化。这些模型将允许因果实验
测试mCa~(2+)摄取是否推动AD的进展。将检查小鼠的记忆力改变,淀粉样变性,
Tau-病理,氧化应激,突触和代谢功能。初步数据表明,线粒体钙摄取
过载会损害错误折叠的蛋白质和功能失调的线粒体的清除。因此,我们将
从机制上考察钙离子交换与自噬和有丝分裂途径之间的联系。
最好的情况是,拟议的研究将发现AD和相关线粒体的新治疗靶点
并提供培训和研究平台,促进PIS的自主研究事业。
英文摘要
Abstract:
Alzheimer's disease (AD) is characterized by the loss of memory accompanied by neuronal cell death and
metabolic dysfunction. Numerous studies have reported a dysregulation in neuronal intracellular calcium
(iCa2+) signaling as an early event in AD pathogenesis. It is thought that a prolonged elevation in neuronal
iCa2+ promotes excessive mitochondrial calcium (mCa2+) uptake, yet to date no study has examined the
contribution of mCa2+ uptake to disease progression. Since mCa2+ flux is an important regulator of cellular
respiration and cell death, both of which are involved in AD pathogenesis, we hypothesize that mCa2+
overload is a key contributor to AD pathology and may contribute to metabolic deficits and neuronal demise.
To define the role of mCa2+ exchange in AD we have generated 3xTg-AD mutant mice with neuronal-specific
deletion of Mitochondrial Calcium Uniporter (MCU), which is required for mCa2+ uptake. In addition, we have
generated a gain-of-function mutant mouse expressing the recently identified mitochondrial calcium uniporter
beta subunit (MCUb). MCUb was recently reported as a negative regulator of mCa2+ uptake and we have
observed substantial changes in its expression in AD. These models will allow causative experimentation to
test if mCa2+ uptake drives AD progression. Mice will be examined for alterations in memory, amyloidosis,
tau-pathology, oxidative stress, synaptic and metabolic function. Preliminary data suggest that mCa2+ uptake
overload impairs the clearance of misfolded proteins and dysfunctional mitochondria. Therefore, we will
mechanistically examine the link between mCa2+ exchange and autophagic and mitophagic pathways.
Optimally, the proposed studies will discover new therapeutic targets for AD and associated mitochondrial
dysfunction and provide a training and research platform to promote the PIs independent research career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial calcium uptake in Alzheimer’s disease
-
批准号:10689146
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer's disease
-
批准号:10239248
-
项目类别:
-
资助金额:$10.41万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer's disease. Admin Supplement
-
批准号:10782299
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
Mitochondrial calcium uptake in Alzheimer’s disease
-
批准号:10668706
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2020
-
负责人:Pooja Jadiya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: